Stratvocate offers a wealth of information and easy-to-use tools for those involved in federal contracting.

Subject: Ophthalmic Adaptive Optics (AO) Retinal Imaging System
Solicitation Number: RFQ-FDA-133666
Notice Type: SOLICIT
NAICS: 334516
Set-Aside: Total Small Business
Notice Published: 06-02-26
Response Due: 06-16-26

Agency: Department of Health and Human Services
Office: FOOD AND DRUG ADMINISTRATION
Contact: Freshta Javid This email address is being protected from spambots. You need JavaScript enabled to view it. Ph: (130) 179-6038
Office Address: Rockville, MD 20852
Place of Performance: Silver Spring, MD 20993


Click for official SAM (FBO) notice, additional information, and accompanying attachments

The Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH), Office of Science and Engineering Laboratories (OSEL), Division of Biomedical Physics (DBP) intends to acquire one (1) Ophthalmic Adaptive Optics (AO) Retinal Imaging System. The system will be used to support retinal imaging research, biomarker development, and regulatory science activities at the FDA White Oak Campus in Silver Spring, Maryland. Delivery and installation shall be made to 10903 New Hampshire Avenue, Building WO62, Room G101, Silver Spring, MD 20993. For complete requirements, terms, and conditions, please refer to the attached Combined Synopsis/Solicitation (CSS) document No. RFQ-FDA-133666 .